Targeted and Untargeted CD137L Fusion Proteins for the …
Groups of mice bearing established Colon 26 tumors were then treated daily ×5 with each fusion protein or 2A to determine their immunotherapeutic potential. Results: Both fusion proteins retained CD137L activity in vitro and …